EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Solid Biosciences Inc. of Commencement of a
Class Action Lawsuit and a Lead Plaintiff Deadline of May 29, 2018
The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Solid Biosciences Inc. ("Solid
Biosciences") (NASDAQ: SLDB) pursuant to the January 25, 2018 initial public offering and/or
between January 25, 2018 and March 14, 2018 . You are hereby
notified that a securities class action lawsuit has been commenced in the United States District Court for the District of
Massachusetts. To get more information go to:
http://www.zlk.com/pslra-d/solid-biosciences-inc?wire=2
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or
obligation to you.
The complaint alleges that throughout the class period Defendants issued materially false and/or misleading statements and/or
failed to disclose that: (1) Solid Bioscience’s lead drug candidate, SGT-001, had a high likelihood of causing adverse events in
patients; (2) the company misled investors regarding the toxicity of SGT-001; and (3) consequently, defendants’ statements in the
Registration Statement regarding Solid Biosciences’ business, operations, and prospects were materially false and/or
misleading.
If you suffered a loss in Solid Biosciences you have until May 29, 2018 to request that the
Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm’s
attorneys have extensive expertise and experience representing investors in securities litigation, and have recovered hundreds of
millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20180417006440/en/